Notícias Navamedic Asa - 0FDB | Ações Bolsa de Valores de Londres

*Ao longo de 3 anos $ 1475.65 apenas $ 590.25

Monitor
Book
Fórum
Rankings
Portfolio
Mundo
Jornal
Scanner
Mais

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.

AI Entrar

Premium

Suporte
(11) 4950 5808
suporte@advfn.com.br
Fale Conosco

LSE

0FDB

Navamedic Asa

Gráfico
Book
Fórum
Negócios
Notícias
Balanços

*Ao longo de 3 anos $ 881.64 apenas $ 352.65

	Cotações em Tempo Real	Book de Ofertas
Bovespa (B3)
BM&F
Índices da Dow Jones
New York Stock Exchange
NASDAQ
American Stock Exchange
Forex
Precious Metal

	Cotações em Tempo Real	Book de Ofertas
Bovespa (B3)
BM&F
Precious Metal

Dados

Notícias

Ferramentas

Mercados

Comunidade

Recursos principais

Follow Feed

Fluxo de Opções

Monitor

Navamedic Asa (0FDB)

Ferramentas de nível profissional para investidores individuais.

Notícias de 0FDB

Navamedic ASA: Renewed contract signed with Vitaflo International Limited

Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in Europe

Navamedic ASA: Record high quarter with above 50 percent growth

Navamedic ASA: Invitation to 2023 3rd quarter presentation

Navamedic ASA - Registration of share capital increase

Navamedic ASA - Mandatory notification of trade by primary insider

NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee options

Navamedic ASA: Significant growth across the business

Navamedic ASA: Invitation to 2023 2nd quarter presentation

Navamedic ASA: Minutes of Annual General Meeting

Updated recommendation by the nomination committee of Navamedic ASA

Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer

Navamedic ASA: Notice of Annual General Meeting

Navamedic ASA Q1 2023: Another strong quarter

Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose Aktiebolag

Fóruns

Seu Histórico Recente

Empresa

Negócios

Popular

Obter o aplicativo

BLACK FRIDAY

Economize até 60%* para TRADER PLUS

1 ano 40%, 2 anos 50% e *3 anos 60%

Tendências Agora

Rankings

Dados

Notícias

Ferramentas

Mercados

Comunidade

Recursos principais

Follow Feed

Fluxo de Opções

Monitor

Navamedic Asa (0FDB) Notícias

Navamedic Asa (0FDB)

Ferramentas de nível profissional para investidores individuais.

Notícias de 0FDB

Navamedic ASA: Renewed contract signed with Vitaflo International Limited

Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in Europe

Navamedic ASA: Record high quarter with above 50 percent growth

Navamedic ASA: Invitation to 2023 3rd quarter presentation

Navamedic ASA - Registration of share capital increase

Navamedic ASA - Mandatory notification of trade by primary insider

NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee options

Navamedic ASA: Significant growth across the business

Navamedic ASA: Invitation to 2023 2nd quarter presentation

Navamedic ASA: Minutes of Annual General Meeting

Updated recommendation by the nomination committee of Navamedic ASA

Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer

Navamedic ASA: Notice of Annual General Meeting

Navamedic ASA Q1 2023: Another strong quarter

Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose Aktiebolag

Fóruns

Seu Histórico Recente

Empresa

Negócios

Popular

Obter o aplicativo

BLACK FRIDAY

Economize até 60%* para TRADER BRASIL

1 ano 40%, 2 anos 50% e *3 anos 60%